









市場行情
/
股票
/
nasdaq-cdxs
/

Codexis Inc

CDXS

1.700USD

+0.040+2.41%

收盤 12/22, 16:00（美東）報價延遲15分鐘

153.48M總市值

虧損本益比TTM



Codexis Inc

1.700

+0.040+2.41%

概覽公司財務分析

概覽

公司

財務

分析

關於 Codexis Inc 公司

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Codexis Inc簡介



公司代碼CDXS

公司名稱Codexis Inc

上市日期Apr 22, 2010

CEOMoore (Alison)

員工數量188

證券類型Ordinary Share

年結日Apr 22

公司地址200 Penobscot Dr

城市REDWOOD CITY

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編94063

電話16504218100

網址https://www.codexis.com/

公司代碼CDXS

上市日期Apr 22, 2010

CEOMoore (Alison)

Codexis Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. David V. Smith

Lead Independent Director

194.28K

+26.74%

Dr. Alison Moore, Ph.D.

President, Chief Executive Officer, Director

177.46K

+91.93%

Mr. Kevin Norrett

Chief Operating Officer

160.27K

+10.73%

Mr. Dennis P. Wolf

Independent Director

138.95K

-6.05%

Dr. Rahul Singhvi

Independent Director

132.05K

+45.00%

Dr. Esther Martinborough, Ph.D.

Independent Director

129.04K

+46.54%

Ms. Cynthia Collins

Independent Director

112.16K

+57.58%

Dr. Raymond De Vre, Ph.D.

Independent Director

87.42K

-1.59%

Mr. Christos Richards

Independent Director

85.13K

+92.83%

Ms. Georgia L. Erbez

Chief Financial Officer

70.64K

-8.12%

名稱

名稱/職務

職務

持股

持股變動

Mr. David V. Smith

Lead Independent Director

194.28K

+26.74%

Dr. Alison Moore, Ph.D.

President, Chief Executive Officer, Director

177.46K

+91.93%

Mr. Kevin Norrett

Chief Operating Officer

160.27K

+10.73%

Mr. Dennis P. Wolf

Independent Director

138.95K

-6.05%

Dr. Rahul Singhvi

Independent Director

132.05K

+45.00%

Dr. Esther Martinborough, Ph.D.

Independent Director

129.04K

+46.54%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

APAC

6.58M

42.93%

America

6.35M

41.44%

EMEA

2.40M

15.63%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

Opaleye Management Inc.

9.95%

BlackRock Institutional Trust Company, N.A.

6.50%

The Vanguard Group, Inc.

5.17%

abrdn Inc.

4.53%

Millennium Management LLC

4.50%

其他

69.34%

持股股東

佔比

Opaleye Management Inc.

9.95%

BlackRock Institutional Trust Company, N.A.

6.50%

The Vanguard Group, Inc.

5.17%

abrdn Inc.

4.53%

Millennium Management LLC

4.50%

其他

69.34%

股東類型

持股股東

佔比

Investment Advisor

27.10%

Hedge Fund

21.96%

Investment Advisor/Hedge Fund

19.88%

Individual Investor

2.88%

Research Firm

1.22%

Pension Fund

0.20%

Bank and Trust

0.18%

Insurance Company

0.03%

Venture Capital

0.02%

其他

26.52%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

259

63.79M

84.44%

-3.19M

2025Q3

270

67.24M

85.39%

-6.33M

2025Q2

272

73.50M

96.12%

+3.66M

2025Q1

304

67.35M

93.04%

-9.72M

2024Q4

323

66.35M

93.32%

+1.38M

2024Q3

331

65.10M

96.64%

+10.35M

2024Q2

345

54.66M

101.93%

-1.25M

2024Q1

358

56.38M

110.38%

-21.50M

2023Q4

374

58.04M

110.76%

+374.07K

2023Q3

379

57.61M

110.71%

-5.54M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Opaleye Management Inc.

12.61M

13.97%

+10.00K

+0.08%

Jul 30, 2025

BlackRock Institutional Trust Company, N.A.

5.85M

6.48%

-376.85K

-6.05%

Jun 30, 2025

The Vanguard Group, Inc.

4.59M

5.08%

-135.73K

-2.87%

Jun 30, 2025

abrdn Inc.

4.20M

4.65%

+3.59M

+592.89%

Jun 30, 2025

Nantahala Capital Management, LLC

4.03M

4.47%

+1.20M

+42.39%

Jun 30, 2025

Telemark Asset Management, LLC

4.00M

4.43%

+1.00M

+33.33%

Jun 30, 2025

Columbia Threadneedle Investments (US)

2.55M

2.83%

+16.10K

+0.64%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.98M

2.19%

+52.59K

+2.73%

Jun 30, 2025

Pier Capital, LLC

1.92M

2.12%

+245.96K

+14.73%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.47%

iShares Micro-Cap ETF

0.04%

Invesco Nasdaq Biotechnology ETF

0.02%

Fidelity Enhanced Small Cap ETF

0.02%

iShares Biotechnology ETF

0.02%

ProShares Ultra Nasdaq Biotechnology

0.02%

Global X Russell 2000 ETF

0.01%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

Proshares Ultra Russell 2000

0.01%

iShares Russell 2000 Growth ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

佔比0.47%

iShares Micro-Cap ETF

佔比0.04%

Invesco Nasdaq Biotechnology ETF

佔比0.02%

Fidelity Enhanced Small Cap ETF

佔比0.02%

iShares Biotechnology ETF

佔比0.02%

ProShares Ultra Nasdaq Biotechnology

佔比0.02%

Global X Russell 2000 ETF

佔比0.01%

Invesco RAFI US 1500 Small-Mid ETF

佔比0.01%

Proshares Ultra Russell 2000

佔比0.01%

iShares Russell 2000 Growth ETF

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Codexis Inc的前五大股東是誰？



Codexis Inc的前五大股東如下：
Opaleye Management Inc.
持有股份：12.61M
佔總股份比例：13.97%。
BlackRock Institutional Trust Company, N.A.
持有股份：5.85M
佔總股份比例：6.48%。
The Vanguard Group, Inc.
持有股份：4.59M
佔總股份比例：5.08%。
abrdn Inc.
持有股份：4.20M
佔總股份比例：4.65%。
Nantahala Capital Management, LLC
持有股份：4.03M
佔總股份比例：4.47%。